206 related articles for article (PubMed ID: 21829175)
1. AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy.
Bortolanza S; Nonis A; Sanvito F; Maciotta S; Sitia G; Wei J; Torrente Y; Di Serio C; Chamberlain JR; Gabellini D
Mol Ther; 2011 Nov; 19(11):2055-64. PubMed ID: 21829175
[TBL] [Abstract][Full Text] [Related]
2. Direct interplay between two candidate genes in FSHD muscular dystrophy.
Ferri G; Huichalaf CH; Caccia R; Gabellini D
Hum Mol Genet; 2015 Mar; 24(5):1256-66. PubMed ID: 25326393
[TBL] [Abstract][Full Text] [Related]
3. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1.
Gabellini D; D'Antona G; Moggio M; Prelle A; Zecca C; Adami R; Angeletti B; Ciscato P; Pellegrino MA; Bottinelli R; Green MR; Tupler R
Nature; 2006 Feb; 439(7079):973-7. PubMed ID: 16341202
[TBL] [Abstract][Full Text] [Related]
4. FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1).
Feeney SJ; McGrath MJ; Sriratana A; Gehrig SM; Lynch GS; D'Arcy CE; Price JT; McLean CA; Tupler R; Mitchell CA
PLoS One; 2015; 10(2):e0117665. PubMed ID: 25695429
[TBL] [Abstract][Full Text] [Related]
5. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation.
Bodega B; Ramirez GD; Grasser F; Cheli S; Brunelli S; Mora M; Meneveri R; Marozzi A; Mueller S; Battaglioli E; Ginelli E
BMC Biol; 2009 Jul; 7():41. PubMed ID: 19607661
[TBL] [Abstract][Full Text] [Related]
6. RNA interference improves myopathic phenotypes in mice over-expressing FSHD region gene 1 (FRG1).
Wallace LM; Garwick-Coppens SE; Tupler R; Harper SQ
Mol Ther; 2011 Nov; 19(11):2048-54. PubMed ID: 21730972
[TBL] [Abstract][Full Text] [Related]
7. Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD).
Pistoni M; Shiue L; Cline MS; Bortolanza S; Neguembor MV; Xynos A; Ares M; Gabellini D
PLoS Genet; 2013; 9(1):e1003186. PubMed ID: 23300487
[TBL] [Abstract][Full Text] [Related]
8. Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD).
Jones TI; Parilla M; Jones PL
PLoS One; 2016; 11(3):e0150938. PubMed ID: 26942723
[TBL] [Abstract][Full Text] [Related]
9. Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein.
Hanel ML; Sun CY; Jones TI; Long SW; Zanotti S; Milner D; Jones PL
Differentiation; 2011 Feb; 81(2):107-18. PubMed ID: 20970242
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
[TBL] [Abstract][Full Text] [Related]
11. RNA interference inhibits DUX4-induced muscle toxicity in vivo: implications for a targeted FSHD therapy.
Wallace LM; Liu J; Domire JS; Garwick-Coppens SE; Guckes SM; Mendell JR; Flanigan KM; Harper SQ
Mol Ther; 2012 Jul; 20(7):1417-23. PubMed ID: 22508491
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional alterations of muscle fibres in the novel mouse model of facioscapulohumeral muscular dystrophy.
D'Antona G; Brocca L; Pansarasa O; Rinaldi C; Tupler R; Bottinelli R
J Physiol; 2007 Nov; 584(Pt 3):997-1009. PubMed ID: 17855756
[TBL] [Abstract][Full Text] [Related]
13. Muscular dystrophy candidate gene FRG1 is critical for muscle development.
Hanel ML; Wuebbles RD; Jones PL
Dev Dyn; 2009 Jun; 238(6):1502-12. PubMed ID: 19097195
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic impact of systemic AAV-mediated RNA interference in a mouse model of myotonic dystrophy.
Bisset DR; Stepniak-Konieczna EA; Zavaljevski M; Wei J; Carter GT; Weiss MD; Chamberlain JR
Hum Mol Genet; 2015 Sep; 24(17):4971-83. PubMed ID: 26082468
[TBL] [Abstract][Full Text] [Related]
15. FSHD muscular dystrophy region gene 1 binds Suv4-20h1 histone methyltransferase and impairs myogenesis.
Neguembor MV; Xynos A; Onorati MC; Caccia R; Bortolanza S; Godio C; Pistoni M; Corona DF; Schotta G; Gabellini D
J Mol Cell Biol; 2013 Oct; 5(5):294-307. PubMed ID: 23720823
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice expressing tunable levels of DUX4 develop characteristic facioscapulohumeral muscular dystrophy-like pathophysiology ranging in severity.
Jones TI; Chew GL; Barraza-Flores P; Schreier S; Ramirez M; Wuebbles RD; Burkin DJ; Bradley RK; Jones PL
Skelet Muscle; 2020 Apr; 10(1):8. PubMed ID: 32278354
[TBL] [Abstract][Full Text] [Related]
17. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M
Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132
[TBL] [Abstract][Full Text] [Related]
18. FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy.
Wuebbles RD; Hanel ML; Jones PL
Dis Model Mech; 2009; 2(5-6):267-74. PubMed ID: 19383939
[TBL] [Abstract][Full Text] [Related]
19. Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?
Richards M; Coppée F; Thomas N; Belayew A; Upadhyaya M
Hum Genet; 2012 Mar; 131(3):325-40. PubMed ID: 21984394
[TBL] [Abstract][Full Text] [Related]
20. Facioscapulohumeral muscular dystrophy.
Tawil R
Curr Neurol Neurosci Rep; 2004 Jan; 4(1):51-4. PubMed ID: 14683629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
